Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity
Ellen Duong, Tim Fessenden, Emi A. Lutz, et al.
Immunity (2021) Vol. 55, Iss. 2, pp. 308-323.e9
Open Access | Times Cited: 222

Showing 1-25 of 222 citing articles:

A neutrophil response linked to tumor control in immunotherapy
Jeremy Gungabeesoon, Nicolas A. Gort-Freitas, Máté Kiss, et al.
Cell (2023) Vol. 186, Iss. 7, pp. 1448-1464.e20
Closed Access | Times Cited: 203
Cancer vaccines: Building a bridge over troubled waters
MacLean C. Sellars, Catherine J. Wu, Edward F. Fritsch
Cell (2022) Vol. 185, Iss. 15, pp. 2770-2788
Open Access | Times Cited: 191
Systemic vaccination induces CD8+ T cells and remodels the tumor microenvironment
Faezzah Baharom, Ramiro A. Ramirez-Valdez, Ahad Khalilnezhad, et al.
Cell (2022) Vol. 185, Iss. 23, pp. 4317-4332.e15
Open Access | Times Cited: 152
Emerging phagocytosis checkpoints in cancer immunotherapy
Yue Liu, Yanjin Wang, Yanrong Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 152
Dendritic cells as orchestrators of anticancer immunity and immunotherapy
Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Miguel Á. Galán, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 257-277
Closed Access | Times Cited: 105
Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing
Brendan W. MacNabb, Xiufen Chen, Sravya Tumuluru, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 982-997.e8
Open Access | Times Cited: 95
Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy
Yi Wang, Kai Conrad Cecil Johnson, Margaret E. Gatti‐Mays, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 93
Dendritic cells as shepherds of T cell immunity in cancer
Mikaël J. Pittet, Mauro Di Pilato, Christopher Garris, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2218-2230
Open Access | Times Cited: 92
Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer
Maria Zagorulya, Leon Yim, Duncan M. Morgan, et al.
Immunity (2023) Vol. 56, Iss. 2, pp. 386-405.e10
Open Access | Times Cited: 87
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses
Felix Bayerl, Philippa Meiser, Sainitin Donakonda, et al.
Immunity (2023) Vol. 56, Iss. 6, pp. 1341-1358.e11
Open Access | Times Cited: 86
A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity
Philippa Meiser, Moritz Knolle, Anna Hirschberger, et al.
Cancer Cell (2023) Vol. 41, Iss. 8, pp. 1498-1515.e10
Open Access | Times Cited: 86
MACHETE identifies interferon-encompassing chromosome 9p21.3 deletions as mediators of immune evasion and metastasis
Francisco M. Barriga, Kaloyan M. Tsanov, Yu-Jui Ho, et al.
Nature Cancer (2022) Vol. 3, Iss. 11, pp. 1367-1385
Open Access | Times Cited: 72
Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Tumor Microenvironment‐Responsive Nanoparticles Amplifying STING Signaling Pathway for Cancer Immunotherapy
Dan Liu, Shuang Liang, Kongshuo Ma, et al.
Advanced Materials (2023) Vol. 36, Iss. 6
Closed Access | Times Cited: 56
Epigenetic state determines the in vivo efficacy of STING agonist therapy
Rana Falahat, Anders Berglund, Patricio Perez-Villarroel, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 42
TME-Related Biomimetic Strategies Against Cancer
Cheng Peng, Yilin Xu, Jing Wu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 109-135
Open Access | Times Cited: 30
Lymphatic-localized Treg-mregDC crosstalk limits antigen trafficking and restrains anti-tumor immunity
Siyuan You, Shuqin Li, Lingsu Zeng, et al.
Cancer Cell (2024) Vol. 42, Iss. 8, pp. 1415-1433.e12
Closed Access | Times Cited: 22
cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors
Guohao Li, Xiangqian Zhao, Zuda Zheng, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 19
Rhein‐based Pickering emulsion for hepatocellular carcinoma: Shaping the metabolic signaling and immunoactivation in transarterial chemoembolization
Xiaoliu Liang, Hui Liu, Hu Chen, et al.
Aggregate (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 19
CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors
Xin Lei, Daniël C. de Groot, Marij J.P. Welters, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 4, pp. 374-392
Open Access | Times Cited: 18
Dendritic cell maturation in cancer
Chang Moon, Meriem Belabed, Matthew D. Park, et al.
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 2
The tumor microenvironment and dendritic cells: Developers of pioneering strategies in colorectal cancer immunotherapy?
Farid Ghorbaninezhad, Mina Afrashteh Nour, Omid Rahbar Farzam, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189281-189281
Closed Access | Times Cited: 2
Parps in immune response: Potential targets for cancer immunotherapy
S Wang, Jingling Huang, T. X. Zeng, et al.
Biochemical Pharmacology (2025) Vol. 234, pp. 116803-116803
Closed Access | Times Cited: 2
Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy
Ting Su, Furong Cheng, Jialong Qi, et al.
Advanced Science (2022) Vol. 9, Iss. 23
Open Access | Times Cited: 57
The Role of Type-2 Conventional Dendritic Cells in the Regulation of Tumor Immunity
Yasuyuki Saito, Satomi Komori, Takenori Kotani, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 1976-1976
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top